2025 Q2 Portfolio Activity
In 2025 Q2, Cutter Capital Management, LP maintained a portfolio of 21 distinct positions.
Position History
hover any row below to update
Loading…
Total Positions
21
Quarter
2025 Q2
Top Holding
BMY (7.8%)
Top 10 Concentration
62.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-21 of 21
Cutter Capital Management, LP Full Holdings List — 2025 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BMY
BRISTOL-MYERS S...
|
Healthcare | 7.83% | 7.83% |
#1
Prev: #1
|
6.1 |
—
|
no change | no change |
P
S
|
295,000 | $17,992,050 | 2023 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
AMGN
AMGEN INC
|
Healthcare | 6.78% | 6.78% |
#2
Prev: #2
|
5.2 |
—
|
no change | no change |
P
S
|
50,000 | $15,577,500 | 2023 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
BIIB
BIOGEN INC
|
Healthcare | 6.76% | 6.76% |
#3
Prev: #3
|
4.7 |
—
|
no change | no change |
P
S
|
113,500 | $15,531,340 | 2024 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 6.47% | 6.47% |
#4
Prev: #4
|
4.1 |
—
|
no change | no change |
P
S
|
18,000 | $14,866,380 | 2024 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
INSM
INSMED INC
|
Healthcare | 6.19% | 6.19% |
#5
Prev: #5
|
4.0 |
—
|
no change | no change |
P
S
|
186,384 | $14,219,235 | 2023 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 5.98% | 5.98% |
#6
Prev: #6
|
3.4 |
—
|
no change | no change |
P
S
|
379,303 | $13,734,562 | 2024 Q2 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 5.88% | 5.88% |
#7
Prev: #7
|
3.4 |
—
|
no change | no change |
P
S
|
390,644 | $13,504,563 | 2023 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
PRGO
PERRIGO CO PLC
|
Healthcare | 5.85% | 5.85% |
#8
Prev: #8
|
3.3 |
—
|
no change | no change |
P
S
|
479,517 | $13,445,657 | 2023 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 5.71% | 5.71% |
#9
Prev: #9
|
3.3 |
—
|
no change | no change |
P
S
|
1,300,000 | $13,117,000 | 2023 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
TEVA
TEVA PHARMACEUT...
|
Healthcare | 5.37% | 5.37% |
#10
Prev: #10
|
3.1 |
—
|
no change | no change |
P
S
|
801,806 | $12,323,758 | 2023 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
RPRX
ROYALTY PHARMA ...
|
Healthcare | 4.84% | 4.84% |
#11
Prev: #11
|
2.9 |
—
|
no change | no change |
P
S
|
356,894 | $11,110,110 | 2023 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 4.59% | 4.59% |
#12
Prev: #12
|
2.8 |
—
|
no change | no change |
P
S
|
205,000 | $10,530,850 | 2024 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
VRNA
VERONA PHARMA P...
|
Unknown | 4.42% | 4.42% |
#13
Prev: #13
|
2.8 |
—
|
no change | no change |
P
S
|
160,000 | $10,158,400 | 2025 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 3.46% | 3.46% |
#14
Prev: #14
|
2.4 |
—
|
no change | no change |
P
S
|
24,000 | $7,949,520 | 2025 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
SMMT
SUMMIT THERAPEU...
|
Healthcare | 3.36% | 3.36% |
#15
Prev: #15
|
2.3 |
—
|
no change | no change |
P
S
|
400,000 | $7,716,000 | 2025 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
HALO
HALOZYME THERAP...
|
Healthcare | 3.33% | 3.33% |
#16
Prev: #16
|
2.3 |
—
|
no change | no change |
P
S
|
120,000 | $7,657,200 | 2023 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 3.06% | 3.06% |
#17
Prev: #17
|
2.2 |
—
|
no change | no change |
P
S
|
175,000 | $7,033,250 | 2024 Q2 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 3.00% | 3.00% |
#18
Prev: #18
|
2.2 |
—
|
no change | no change |
P
S
|
235,350 | $6,895,755 | 2024 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 2.62% | 2.62% |
#19
Prev: #19
|
2.0 |
—
|
no change | no change |
P
S
|
418,127 | $6,012,666 | 2024 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
RCUS
ARCUS BIOSCIENC...
|
Healthcare | 2.50% | 2.50% |
#20
Prev: #20
|
2.0 |
—
|
no change | no change |
P
S
|
731,818 | $5,744,771 | 2023 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 1.97% | 1.97% |
#21
Prev: #21
|
1.8 |
—
|
no change | no change |
P
S
|
221,152 | $4,526,981 | 2024 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) |
Showing 1-21 of 21 holdings